Trump Cuts a Deal With AstraZeneca to Lower Drug Prices

President Trump has successfully negotiated a deal with AstraZeneca to lower drug prices, a move that could significantly impact healthcare costs for many Americans. By leveraging tariff threats, the administration aims to encourage other pharmaceutical companies to follow suit, potentially leading to broader reforms in drug pricing. This agreement not only highlights the administration's commitment to making medications more affordable but also sets a precedent for future negotiations in the healthcare sector.